TCF21 and cardiac hypertrophy: Xiang and colleagues showed that the conditional genetic loss of β-catenin in heart fibroblast (Transcription factor 21 (TCF21) + cells) and activated fibroblasts and myofibroblasts (Periostin+) lineages reduces fibrosis and ameliorates cardiac hypertrophy induced by pressure overload [164].